Original Investigation

Methylphenidate Treatment and Risk of Psychotic Disorder

JAMA Psychiatry 10.1001/jamapsychiatry.2026.0152

March 25, 2026 at 11:00 AM EDT

Read the full article

Does methylphenidate alter the long-term risk of psychotic disorder in children with attention-deficit/hyperactivity disorder (ADHD)?This cohort study of a Finnish national multiyear birth cohort, using instrumental variable analysis, did not find an overall difference in the long-term risk of psychotic disorders in children and adolescents diagnosed with ADHD who were treated with methylphenidate. Looking specifically at childhood (age <13 years) ADHD diagnoses, there was a potential protective effect of sustained methylphenidate treatment against subsequent risk of psychotic disorder.Methylphenidate treatment of ADHD may have a protective effect against psychosis in individuals diagnosed in childhood.

Corresponding Author: Ian Kelleher, MD, PhD, Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (ian.kelleher@ed.ac.uk).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks